Orthofix and SeaSpine to Combine in Merger of Equals

Companion Spine Acquires Coflex and CoFix Implants and Paradigm Spine from Xtant Medical

July 8, 2025

Medical Devices

Companion Spine LLC entered into a definitive agreement to acquire Coflex and CoFix spine implant assets and all OUS entities of Paradigm Spine GmbH from Xtant Medical Holdings, Inc., with completion expected in 3Q 2025. The transaction totals $19.2 million, including cash at closing and short-term seller financing, and is intended to strengthen Companion Spine’s global posterior dynamic spine stabilization and motion preservation portfolio.

Demetra S.p.A. Acquires OrthoFundamentals, LLC and Launches Demetra Spine

August 1, 2025

Medical Devices

Demetra S.p.A. has completed the full acquisition of OrthoFundamentals, LLC, a U.S.-based maker of sterile-packed, single-use implants and instrument kits for sacroiliac (SI) joint fusion. The deal enables Demetra to launch Demetra Spine, expanding its product offering into spine surgery and strengthening its presence in the U.S. outpatient Ambulatory Surgery Center (ASC) market.

LMF Acquisition Opportunities SPAC Merges with SeaStar Medical in $85 Million Medical Technology Deal

May 3, 2022

Medical Devices

Skyway Capital Markets is advising on the proposed merger of SeaStar Medical, a medical technology company developing extracorporeal immunomodulatory therapies, with LMF Acquisition Opportunities, Inc. (Nasdaq: LMAO), a publicly traded special purpose acquisition company. The transaction is expected to give SeaStar Medical access to capital markets to accelerate development of its lead program for acute kidney injury (AKI) and advance additional acute and chronic indications.

Vizgen Acquires Ultivue (Merger to Form Combined Spatial Biology Company)

October 9, 2024

Biotechnology

Vizgen and Ultivue have merged to create a single spatial biology company that combines Vizgen’s MERFISH single-cell spatial genomics platform with Ultivue’s InSituPlex assays and STARVUE proteomic/AI capabilities. Rob Carson (former CEO of Ultivue) will serve as President and CEO of the combined Vizgen, and the transaction was completed alongside Vizgen’s Series D financing backed by investors including ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.

Transocean to Acquire Valaris in $5.8 Billion All-Stock Deal

February 9, 2026

Energy

Transocean and Valaris have signed a definitive agreement to combine in an all-stock transaction valued at approximately $5.8 billion, with Transocean acquiring Valaris. The deal is structured as a court-approved scheme of arrangement under Bermuda law and is expected to close in the second half of 2026, subject to regulatory and shareholder approvals.

Boston Scientific Acquires Vertiflex from H.I.G. BioHealth Partners

June 18, 2019

Medical Devices

Boston Scientific acquired Vertiflex, Inc., a Carlsbad-based developer of the Superion interspinous spacer for lumbar spinal stenosis, for approximately $465 million in cash plus contingent payments. The transaction was announced in May 2019 and completed in June 2019; Vertiflex had been backed by H.I.G. BioHealth Partners.